• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微管稳定剂 peloruside A 对 HL-60 细胞蛋白质组的影响。

Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells.

机构信息

Centre for Biodiscovery and School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.

出版信息

Invest New Drugs. 2011 Aug;29(4):544-53. doi: 10.1007/s10637-010-9387-5. Epub 2010 Jan 27.

DOI:10.1007/s10637-010-9387-5
PMID:20107863
Abstract

Peloruside A, isolated from the marine sponge Mycale hentscheli, has a similar mechanism of action to paclitaxel (Taxol®), a drug used clinically to treat tumors of the breast, ovary and lung. Paclitaxel and peloruside stabilize the polymerized form of tubulin and arrest cells in G₂/M of the cell cycle. We have therefore used two-dimensional electrophoresis of proteins to examine the effect of peloruside A on the human HL-60 promyeloid leukemic cell line. Our goals included investigation whether affected proteins could be mapped onto pathways that predicted the cellular effects of this compound. In response to 100 nM peloruside A treatment for 24 h, seventeen identified proteins showed significant change in abundance with fourteen increases and three decreases. Use of Ingenuity Pathways Analysis confirmed that peloruside A affected pathways consistent with the known effects on microtubules and apoptosis. Our results also indicate a potential role of c-Myc in the cellular actions of peloruside consistent with an induction of aneuploidy seen at low concentrations of peloruside.

摘要

从海洋海绵 Mycale hentscheli 中分离得到的 Peloruside A 与紫杉醇(Taxol®)具有相似的作用机制,紫杉醇是一种临床上用于治疗乳腺癌、卵巢癌和肺癌的药物。紫杉醇和 Peloruside A 稳定微管蛋白的聚合形式,并将细胞阻滞在细胞周期的 G₂/M 期。因此,我们使用二维电泳技术研究了 Peloruside A 对人 HL-60 早幼粒细胞白血病细胞系的影响。我们的目标包括研究受影响的蛋白质是否可以映射到预测该化合物细胞作用的途径上。在对 100 nM Peloruside A 处理 24 小时后,有 17 种鉴定出的蛋白质的丰度发生了显著变化,其中 14 种增加,3 种减少。使用 Ingenuity Pathways Analysis 证实,Peloruside A 影响的途径与已知的对微管和细胞凋亡的作用一致。我们的结果还表明,c-Myc 在 Peloruside A 的细胞作用中可能发挥作用,这与在低浓度 Peloruside 下观察到的非整倍体的诱导一致。

相似文献

1
Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells.微管稳定剂 peloruside A 对 HL-60 细胞蛋白质组的影响。
Invest New Drugs. 2011 Aug;29(4):544-53. doi: 10.1007/s10637-010-9387-5. Epub 2010 Jan 27.
2
Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.紫杉醇对 HL-60 早幼粒细胞白血病细胞蛋白质组的影响:与 peloruside A 的比较。
Invest New Drugs. 2012 Feb;30(1):121-9. doi: 10.1007/s10637-010-9540-1. Epub 2010 Sep 23.
3
Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.Peloruside A,一种具有类似紫杉醇微管稳定活性的新型抗有丝分裂剂。
Cancer Res. 2002 Jun 15;62(12):3356-60.
4
Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines.Peloruside A在培养的癌细胞系中与其他微管稳定剂协同作用。
Mol Pharm. 2007 Mar-Apr;4(2):269-80. doi: 10.1021/mp060101p.
5
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.佩罗利司德 A:一种潜在的针对癌症、神经退行性疾病和自身免疫性疾病的有活性的、非紫杉烷类微管稳定剂先导化合物。
Nat Prod Rep. 2016 Apr;33(4):549-61. doi: 10.1039/c5np00146c. Epub 2016 Feb 12.
6
Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A.微管稳定剂 peloruside A 诱导加速衰老。
Invest New Drugs. 2017 Dec;35(6):706-717. doi: 10.1007/s10637-017-0493-5. Epub 2017 Jul 22.
7
Peloruside B, a potent antitumor macrolide from the New Zealand marine sponge Mycale hentscheli: isolation, structure, total synthesis, and bioactivity.佩洛里德 B,一种来自新西兰海洋海绵 Mycale hentscheli 的强效抗肿瘤大环内酯:分离、结构、全合成和生物活性。
J Org Chem. 2010 Jan 1;75(1):2-10. doi: 10.1021/jo9021265.
8
Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines.Peloruside A不与β-微管蛋白上的紫杉烷类位点结合,并在多药耐药细胞系中保持其活性。
Cancer Res. 2004 Aug 1;64(15):5063-7. doi: 10.1158/0008-5472.CAN-04-0771.
9
Peloruside A inhibits microtubule dynamics in a breast cancer cell line MCF7.Peloruside A 抑制乳腺癌细胞系 MCF7 中的微管动态。
Invest New Drugs. 2011 Aug;29(4):615-26. doi: 10.1007/s10637-010-9398-2. Epub 2010 Feb 20.
10
Chemical genetic profiling of the microtubule-targeting agent peloruside A in budding yeast Saccharomyces cerevisiae.在芽殖酵母酿酒酵母中对微管靶向药物 peloruside A 进行化学遗传分析。
Gene. 2012 Apr 15;497(2):140-6. doi: 10.1016/j.gene.2012.01.072. Epub 2012 Feb 4.

引用本文的文献

1
Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cells.Peloruside A,一种微管稳定剂,可诱导卵巢癌细胞出现非整倍体。
Invest New Drugs. 2016 Aug;34(4):424-38. doi: 10.1007/s10637-016-0355-6. Epub 2016 May 7.
2
Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A.微管稳定剂peloruside A对人血管内皮细胞迁移和毛细血管样管形成的抑制作用。
Invest New Drugs. 2015 Jun;33(3):564-74. doi: 10.1007/s10637-015-0232-8. Epub 2015 Mar 31.
3
Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.

本文引用的文献

1
Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform.不均一核核糖核蛋白K抑制促凋亡Bcl-xS剪接异构体的产生。
J Biol Chem. 2009 Aug 7;284(32):21458-67. doi: 10.1074/jbc.M109.019711. Epub 2009 Jun 11.
2
MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.MYC可防止细胞凋亡,并增强紫杉醇诱导的核内复制。
PLoS One. 2009;4(5):e5442. doi: 10.1371/journal.pone.0005442. Epub 2009 May 6.
3
The algal metabolite yessotoxin affects heterogeneous nuclear ribonucleoproteins in HepG2 cells.
紫杉醇对 HL-60 早幼粒细胞白血病细胞蛋白质组的影响:与 peloruside A 的比较。
Invest New Drugs. 2012 Feb;30(1):121-9. doi: 10.1007/s10637-010-9540-1. Epub 2010 Sep 23.
4
Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.海洋海绵来源的微管稳定剂药物:聚焦于佩洛里德斯 A 和赞那醇。
Mar Drugs. 2010 Mar 31;8(4):1059-79. doi: 10.3390/md8041059.
藻类代谢产物岩沙海葵毒素影响HepG2细胞中的不均一核核糖核蛋白。
Proteomics. 2009 May;9(9):2529-42. doi: 10.1002/pmic.200800725.
4
A unique mode of microtubule stabilization induced by peloruside A.由Peloruside A诱导的独特微管稳定模式。
J Mol Biol. 2008 May 16;378(5):1016-30. doi: 10.1016/j.jmb.2008.03.026. Epub 2008 Mar 19.
5
Proteomic analysis of microsomes from lactating bovine mammary gland.泌乳期奶牛乳腺微粒体的蛋白质组学分析
J Proteome Res. 2008 Apr;7(4):1427-32. doi: 10.1021/pr700819b. Epub 2008 Mar 7.
6
Proteome response in HT-29 human colorectal cancer cells to two apoptosis-inducing compounds with different mode of action.HT-29人结肠癌细胞对两种作用方式不同的凋亡诱导化合物的蛋白质组反应。
Int J Cancer. 2008 May 15;122(10):2223-32. doi: 10.1002/ijc.23387.
7
Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5.用S-三苯甲基-L-半胱氨酸对凋亡信号进行蛋白质组分析,S-三苯甲基-L-半胱氨酸是一种有效的人有丝分裂驱动蛋白Eg5可逆抑制剂。
Proteomics. 2008 Jan;8(2):289-300. doi: 10.1002/pmic.200700534.
8
Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.对不同类型抗癌药物具有化学抗性的MCF-7乳腺癌细胞的蛋白质组学分析。
Int J Oncol. 2007 Jun;30(6):1545-51.
9
Peloruside A, an antimitotic agent, specifically decreases tumor necrosis factor-alpha production by lipopolysaccharide-stimulated murine macrophages.Peloruside A是一种抗有丝分裂剂,它能特异性地降低脂多糖刺激的小鼠巨噬细胞中肿瘤坏死因子-α的产生。
Exp Biol Med (Maywood). 2007 May;232(5):607-13.
10
Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines.Peloruside A在培养的癌细胞系中与其他微管稳定剂协同作用。
Mol Pharm. 2007 Mar-Apr;4(2):269-80. doi: 10.1021/mp060101p.